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Objective: Bladder outlet obstruction (BOO) in women remains an underdiagnosed condition.
Although diagnosed rarely in general urologic practice, its incidence in specialist centers has been reported to be up to 29%. In the present study we evaluated the incidence of female BOO in adult women referred for evaluation of lower urinary tract symptoms or urinary incontinence, assessing its etiology and correlating this with its clinical presentation.
Methods:
The present study consisted of a retrospective review of a prospectively acquired videourodynamic database of 1142 consecutive women referred for evaluation of lower urinary tract symptoms (LUTS) or urinary incontinence from March 2007 to December 2012 and diagnosed with BOO. After exclusions, data from 1014 patients were analyzed. BOO was defined using a combination of radiographic evidence of obstruction during the voiding phase of the urodynamic study and pressure-flow criteria (Solomon-Greenwell nomogram). Diagnosis was confirmed by cystoscopy, maximal urethral closure pressure, and magnetic resonance imaging as clinically indicated.
Results: In all, 192 women (19%) were diagnosed with BOO. Functional sphincteric obstruction was diagnosed in 70 women (36%). The most common anatomical cause of BOO was previous anti-incontinence surgery, followed by urethral stricture, diagnosed in 21% and 20% of patients, respectively. The most common presenting symptoms were storage phase symptoms of daytime and night-time urinary frequency.
Conclusions: BOO was present in 19% of women with LUTS. Functional sphincteric obstruction was the most common cause (36%), followed by obstruction after anti-incontinence surgery (21%). The most common presenting symptom was daytime urinary frequency. BOO should be suspected in women with refractory LUTS, especially those presenting with urinary frequency.
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| INTRODUCTION
Bladder outlet obstruction (BOO) is a highly prevalent cause of voiding lower urinary tract symptoms (LUTS) in men, for which universally accepted nomograms based on pressure-flow parameters exist for accurate diagnosis.
1 This is not the case for women, in whom the prevalence of BOO and its clinical characteristics have been less well studied. The lack of well-established diagnostic criteria contributes to this underdiagnosis. Estimates of prevalence among women undergoing urodynamic evaluation for LUTS vary widely from 2.7% to 29%
due, in large part, to the different definitions used to diagnose BOO in these studies. [2] [3] [4] [5] A number of diagnostic criteria and nomograms based on various urodynamic parameters have been reported, although none of these has gained widespread acceptance due to limitations in diagnostic accuracy. 2, 6, 7 Furthermore, the symptoms of BOO in women may be non-specific and the classic voiding LUTS of poor flow, hesitancy and intermittency seen in men may be less prominent, making diagnosis difficult. 8 Finally, this condition is often not suspected in women, and so its diagnosis and treatment is typically significantly delayed.
There are a large number of causes of BOO in women that can broadly be divided into functional and anatomical conditions. 9 Treatment varies widely depending upon the etiology, and so accurate diagnosis not only of BOO, but also of the underlying cause, is essential for appropriate and successful management. The presence of radiographic evidence of obstruction on videourodynamic investigation has been proposed to facilitate accurate diagnosis, 10 and we have used this in combination with urodynamic criteria developed at University College Hospital London to more accurately diagnose BOO with a higher sensitivity and specificity than the currently reported diagnostic criteria.
11
In the present study we analyzed our research groups prospective videourodynamic database in order to determine the prevalence of BOO in women based on our previously developed diagnostic criteria 11 to assess its etiology and to correlate this with clinical and urodynamic characteristics.
| METHODS
In the present study, a retrospective review was performed of a pro- 12 , UI, recurrent urinary tract infection (UTI), and urethral pain. Subsequently, videourodynamic studies were performed using a 6-Fr dual-lumen catheter according to ICS recommendations. 13 Women undergoing videourodynamic studies either had mixed voiding and storage symptoms or had failed a previous surgical procedure, and so were recommended to undergo videourodynamic evaluation as per National Institute for Heath and Care Excellence (NICE) 14 and European Association of Urology (EAU) guidelines. 15 Filling cystometry was performed at a rate of 50 mL/min with radiographic contrast solution, and fluoroscopic images were obtained periodically during the filling phase and on voiding. One voiding cycle was typically performed, but if a patient's symptoms were not reproduced, or the void was atypical for the patient (as reported on direct questioning of the patient), the cycle was repeated. Further investigation to identify the cause of BOO was performed as clinically indicated and consisted of urethral pressure profilometry (UPP), magnetic resonance imaging (MRI) and cystourethroscopy. UPP was performed using a perfusion catheter technique with a steady infusion rate of 2 mL/min and a withdrawal rate of 1 mm/s using a mechanical arm. In the present study, elevated maximal urethral closure pressure (MUCP) was considered to be one that was above the expected age-related pressure based on the formula MUCP (cmH 2 O) = (92 -patient age in years), as described by Edwards and Malvern. 16 MRI was performed if an anatomical abnormality was suspected (e.g. urethral diverticulum), and cystourethroscopy was used to differentiate urethral stricture from functional BOO. Women under the age of 18 years (n = 17), those who could not void with the urodynamic lines in (n = 6), and those with neurological disorders (n = 105) were excluded from the present analysis (based on neurological history, clinical examination and spinal MRI). In all, 128 patients were excluded from the study, resulting in data from 1014 patients available for analysis.
Only patients with a diagnosis of BOO for whom we had complete data were included in the analysis. Bladder outflow obstruction was defined using a combination of radiographic evidence of obstruction during the voiding phase of the urodynamic study in the presence of a sustained voiding pressure (as per Nitti et al. 
| Statistical analysis
Unless indicated otherwise, data are presented as the mean AE SD for continuous variables and as frequencies and percentages for categorical variables. Analysis of variance (ANOVA) and t-tests were used for comparisons of continuous variables, whereas Chi-squared tests were used for comparisons of categorical variables. Two-sided P < .05 was considered significant. respectively; P = .07).
| RESULTS
The presenting symptoms of women with BOO were categorized according to underlying cause and are listed in Tables 2 and 3 . Presenting symptoms were assessed from clinical history alone because there is no validated symptom pro forma for female BOO. The most common presenting symptoms were storage phase symptoms of daytime and night-time urinary frequency in 132 (69%) and 128 (67%) patients, respectively. This compared with an incidence of daytime and night-time urinary frequency of 26% and 16% in unobstructed patients, respectively. On direct questioning, voiding symptoms of reduced flow and incomplete emptying were experienced by 116 (60%) and 122 (64%) patients, respectively, and 9 (5%) had an indwelling catheter for urinary retention. 
| DISCUSSION
Despite the renewed interest in the diagnosis of female BOO in recent years, the condition remains underdiagnosed due to the lack of universally accepted diagnostic criteria. Numerous authors have 7 In this study, using the optimal cut-off value of Qmax ≤15 mL/s and pdet (4) 213 (26) 131 (16) 419 (51) 82 (10) 608 (74) Abbreviations: BOO, bladder outlet obstruction; HTNRS, high-tone non-relaxing sphincter; UUI, urge urinary incontinence; UTI, urinary tract infection.
Data show the number of patients in each group, with percentages in parentheses. (11) 57 (7) 16 (2) Abbreviations: BOO, bladder outlet obstruction; HTNRS, high-tone non-relaxing sphincter.
Data show the number of patients in each group, with percentages in parentheses. Abbreviations: BOO, bladder outlet obstruction; DO, detrusor overactivity; HTNRS, high-tone non-relaxing sphincter; pdet, detrusor pressure; Qmax, maximum flow.
Data are given as the mean AE SD or as n (%).
Qmax>20 cmH 2 O, BOO was diagnosed in 20% of subjects. However, in the present study, BOO was predefined on the basis of clinical radiographic evidence of BOO. 24 The reported prevalence of 19% in the present study is similar to that reported from other specialist centers 2 using a combination of pressure-flow and radiographic criteria, although the prevalence in general urological practice is likely to be lower.
In the present study population, the most common cause of BOO was functional obstruction due to an HTNRS in 36% of subjects, followed by obstruction due to anti-incontinence surgery and urethral stricture in 21% and 20% of subjects, respectively. Obstruction due to pelvic organ prolapse, urethral diverticula, and paraurethral masses accounted for the remaining cases. Brucker et al. 17 found that functional obstruction was the cause of 45.2% of cases in their series, with primary bladder neck obstruction accounting for 10.2% of cases and sphincteric obstruction the remainder. Urethral stricture disease was diagnosed in 16.6% of subjects in that study. 17 Similarly, Kuo 8 identified functional obstruction as the cause of BOO in most patients, and divided these into bladder neck obstruction, sphincteric obstruction, and pelvic floor obstruction; stricture was diagnosed less commonly, in 6.7% of subjects. In the present study, no cases of primary bladder neck obstruction were identified. In addition, we feel that sphincteric obstruction and pelvic floor muscle obstruction cannot be accurately distinguished in videourodynamic studies, and so have not reported these as separate entities. Unlike
Brucker et al., 25 we did not find any difference in urodynamic parameters between those with functional and anatomical obstruction in the present study. Urethral stricture disease in women is a relatively uncommon condition, reported to account for 4%-13% of cases of BOO in women. 26 The relatively high prevalence of urethral stricture in the present study population is likely to be related to the nature of our specialist practice and referral pattern.
When assessing clinical characteristics of women with BOO, we found storage LUTS to be the most prevalent, with urinary frequency the most common symptom. Voiding symptoms (poor flow)
were reported by 60% of women overall, but were highest in patients with anatomical obstruction, especially urethral stricture (92%). Urinary retention requiring indwelling catheterization was seen more commonly in women with functional obstruction. Urethral pain (41%) and recurrent UTIs (46%) were most commonly reported by patients with urethral stricture disease. This finding has been reported by others, with Kuo 8 reporting storage symptoms as the most common complaint in women with BOO, and so a high index of suspicion should be maintained for any women presenting with storage LUTS that are refractory to initial treatment. We found voiding symptoms to be more common in patients with anatomical obstruction, which may be due to the fixed nature of the obstruction in anatomical causes compared with the more dynamic obstruction seen with functional causes. Nitti et al. 10 found that on careful direct questioning, voiding LUTS can be elicited in most women with BOO, and we feel that all women with refractory LUTS should specifically undergo videourodynamic voiding phase assessment in order to identify BOO.
The relatively large study population with complete investigation and excellent follow-up are strengths of the present study. However, it should be noted that these findings are from a specialist tertiary referral center and, as such, represent a specialized population. A potential limitation of the present study is the fact that we did not assess patients for the presence of detrusor underactivity, which could coexist with BOO. However, there are currently no nomograms that accurately assesses detrusor underactivity in women, and we used the radiographic criteria described by Nitti et al. 10 as 1 of the criteria to diagnose BOO. Other limitations of the present analysis include the retrospective analysis of data and lack of a validated patient-reported outcome measure to assess LUTS, as well as a lack of follow-up urodynamic studies to confirm resolution of BOO after treatment of the underlying cause.
| Conclusion
In the present study in a specialist center, BOO was diagnosed in 
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